Shivanta Impex

Nintedoc 100 Soft Gelatin Capsule
Composition: Nintedanib Soft Gelatin Capsules 100mg
International Trade Name: Ofev® / Vargatef®

Nintedoc 100 is a high-quality Nintedanib 100mg Soft Gelatin Capsule, a generic equivalent of the internationally recognized tyrosine kinase inhibitor marketed as Ofev® and Vargatef®. Manufactured in WHO-GMP certified facilities, Nintedoc 100 Capsules are supplied by trusted pharmaceutical exporters from India to support global pulmonology and oncology treatment programs.

Nintedanib is a small-molecule tyrosine kinase inhibitor that inhibits multiple growth factor receptors, including VEGFR, FGFR, and PDGFR, thereby slowing disease progression in fibrotic lung disorders and suppressing tumor angiogenesis. Nintedoc 100 Capsules are primarily indicated for the treatment of idiopathic pulmonary fibrosis (IPF), progressive fibrosing interstitial lung diseases (ILDs), and non-small cell lung cancer (NSCLC) under specific therapeutic protocols.

High-ranking search keywords include: Nintedanib 100mg capsule, Nintedoc 100 capsule, Ofev generic capsule, Vargatef generic capsule, nintedanib price, idiopathic pulmonary fibrosis treatment, ILD medication, nintedanib exporter India, and tyrosine kinase inhibitor capsule supplier.

Nintedoc 100 Nintedanib Soft Gelatin Capsules are manufactured under strict GMP quality standards, ensuring consistent potency, accurate dosing, and long-term stability. The capsules are supplied in secure, export-grade packaging with complete regulatory documentation, making them suitable for pulmonology clinics, oncology centers, specialty pharmacies, and international pharmaceutical distributors.

Nindanib 150 Soft Gelatin Capsule
Composition: Nintedanib Soft Gelatin Capsules 150mg
International Trade Name: Ofev® / Vargatef®

Nindanib 150 is a high-quality Nintedanib 150mg Soft Gelatin Capsule, a generic equivalent of the internationally recognized tyrosine kinase inhibitor marketed under the brand names Ofev® and Vargatef®. Manufactured in WHO-GMP certified facilities, Nindanib 150 Capsules are supplied by trusted pharmaceutical exporters from India to support global pulmonology and oncology treatment programs.

Nintedanib is a small-molecule tyrosine kinase inhibitor that blocks multiple growth factor receptors, including VEGFR, FGFR, and PDGFR, thereby reducing fibrotic activity and inhibiting tumor angiogenesis. Nindanib 150 Capsules are primarily indicated for the treatment of idiopathic pulmonary fibrosis (IPF), progressive fibrosing interstitial lung diseases (ILDs), and non-small cell lung cancer (NSCLC) in defined clinical settings.

High-ranking search keywords include: Nintedanib 150mg capsule, Nindanib 150 capsule, Ofev generic capsule, Vargatef generic capsule, nintedanib price, idiopathic pulmonary fibrosis treatment, ILD therapy, nintedanib exporter India, and tyrosine kinase inhibitor capsule supplier.

Nindanib 150 Nintedanib Soft Gelatin Capsules are manufactured under strict GMP quality standards, ensuring consistent potency, accurate dosing, and long-term stability. The capsules are supplied in secure, export-grade packaging with full regulatory documentation, making them suitable for pulmonology clinics, oncology centers, specialty pharmacies, hospital supply chains, and international pharmaceutical distributors.

Nindanib 100 Soft Gelatin Capsule
Composition: Nintedanib Soft Gelatin Capsules 100mg
International Trade Name: Ofev® / Vargatef®

Nindanib 100 is a high-quality Nintedanib 100mg Soft Gelatin Capsule, a generic equivalent of the internationally recognized tyrosine kinase inhibitor marketed under the brand names Ofev® and Vargatef®. Manufactured in WHO-GMP certified facilities, Nindanib 100 Capsules are supplied by trusted pharmaceutical exporters from India to support global pulmonology and oncology treatment programs.

Nintedanib is a small-molecule tyrosine kinase inhibitor that inhibits multiple growth factor receptors, including VEGFR, FGFR, and PDGFR, thereby slowing disease progression in fibrotic lung disorders and suppressing tumor angiogenesis. Nindanib 100 Capsules are primarily indicated for the treatment of idiopathic pulmonary fibrosis (IPF), progressive fibrosing interstitial lung diseases (ILDs), and non-small cell lung cancer (NSCLC) under defined therapeutic protocols.

High-ranking search keywords include: Nintedanib 100mg capsule, Nindanib 100 capsule, Ofev generic capsule, Vargatef generic capsule, nintedanib price, idiopathic pulmonary fibrosis treatment, ILD medication, nintedanib exporter India, and tyrosine kinase inhibitor capsule supplier.

Nindanib 100 Nintedanib Soft Gelatin Capsules are manufactured under stringent GMP quality standards, ensuring consistent potency, accurate dosing, and long-term stability. The capsules are supplied in secure, export-grade packaging with complete regulatory documentation, making them suitable for pulmonology clinics, oncology centers, specialty pharmacies, hospital procurement teams, and international pharmaceutical distributors.

Nintib 150 Soft Gelatin Capsule
Composition: Nintedanib Soft Gelatin Capsules 150mg
International Trade Name: Ofev® / Vargatef®

Nintib 150 is a high-quality Nintedanib 150mg Soft Gelatin Capsule, a generic equivalent of the internationally recognized tyrosine kinase inhibitor marketed under the brand names Ofev® and Vargatef®. Manufactured in WHO-GMP certified facilities, Nintib 150 Capsules are supplied by trusted pharmaceutical exporters from India to support global pulmonology and oncology treatment programs.

Nintedanib is a small-molecule tyrosine kinase inhibitor that blocks multiple growth factor receptors, including VEGFR, FGFR, and PDGFR, thereby reducing fibrotic activity and inhibiting tumor angiogenesis. Nintib 150 Capsules are primarily indicated for the treatment of idiopathic pulmonary fibrosis (IPF), progressive fibrosing interstitial lung diseases (ILDs), and non-small cell lung cancer (NSCLC) in specific clinical settings.

High-ranking search keywords include: Nintedanib 150mg capsule, Nintib 150 capsule, Ofev generic capsule, Vargatef generic capsule, nintedanib price, idiopathic pulmonary fibrosis treatment, ILD therapy, nintedanib exporter India, and tyrosine kinase inhibitor capsule supplier.

Nintib 150 Nintedanib Soft Gelatin Capsules are manufactured under strict GMP quality standards, ensuring consistent potency, accurate dosing, and long-term stability. The capsules are supplied in secure, export-grade packaging with full regulatory documentation, making them suitable for pulmonology clinics, oncology centers, specialty pharmacies, hospital procurement teams, and international pharmaceutical distributors.

Nintib 100 Soft Gelatin Capsule
Composition: Nintedanib Soft Gelatin Capsules 100mg
International Trade Name: Ofev® / Vargatef®

Nintib 100 is a high-quality Nintedanib 100mg Soft Gelatin Capsule, a generic equivalent of the internationally recognized tyrosine kinase inhibitor marketed under the brand names Ofev® and Vargatef®. Manufactured in WHO-GMP certified facilities, Nintib 100 Capsules are supplied by trusted pharmaceutical exporters from India to support global pulmonology and oncology treatment programs.

Nintedanib is a small-molecule tyrosine kinase inhibitor that blocks multiple growth factor receptors, including VEGFR, FGFR, and PDGFR, thereby reducing fibrotic activity and inhibiting tumor angiogenesis. Nintib 100 Capsules are primarily indicated for the treatment of idiopathic pulmonary fibrosis (IPF), progressive fibrosing interstitial lung diseases (ILDs), and non-small cell lung cancer (NSCLC) in specific clinical settings.

High-ranking search keywords include: Nintedanib 100mg capsule, Nintib 100 capsule, Ofev generic capsule, Vargatef generic capsule, nintedanib price, idiopathic pulmonary fibrosis treatment, ILD therapy, nintedanib exporter India, and tyrosine kinase inhibitor capsule supplier.

Nintib 100 Nintedanib Soft Gelatin Capsules are manufactured under strict GMP quality standards, ensuring consistent potency, accurate dosing, and long-term stability. The capsules are supplied in secure, export-grade packaging with complete regulatory documentation, making them suitable for pulmonology clinics, oncology centers, specialty pharmacies, hospital procurement teams, and international pharmaceutical distributors.

Vivitra 375mg Injection
Composition: Trastuzumab Injection 375mg
International Trade Name: Herceptin®

Vivitra 375 is a high-quality Trastuzumab 375mg Injection, a biosimilar/generic equivalent of the internationally recognized HER2-targeted monoclonal antibody marketed under the brand name Herceptin®. Manufactured in WHO-GMP certified facilities under stringent biologics production standards, Vivitra 375 Injection is supplied by trusted pharmaceutical exporters from India to support global oncology and breast cancer treatment programs.

Trastuzumab is a humanized monoclonal antibody that selectively binds to the HER2 receptor, inhibiting HER2-mediated signaling pathways and inducing antibody-dependent cellular cytotoxicity (ADCC). Vivitra 375 Injection is primarily indicated for the treatment of HER2-positive breast cancer and HER2-positive gastric or gastroesophageal junction adenocarcinoma, administered alone or in combination with chemotherapy according to established treatment protocols.

High-ranking search keywords include: Trastuzumab 375mg injection, Vivitra 375 injection, Herceptin biosimilar, trastuzumab price, HER2 positive breast cancer treatment, trastuzumab exporter India, oncology monoclonal antibody supplier, and breast cancer biologic manufacturer India.

Vivitra 375 Trastuzumab Injection is manufactured under strict GMP and cold-chain controlled conditions, ensuring molecular integrity, consistent potency, and long-term stability. The injection is supplied in secure, export-grade packaging with complete regulatory and cold-chain documentation, making it suitable for hospital oncology centers, cancer institutes, government tenders, specialty distributors, and international pharmaceutical supply chains.

Canmab 150mg Injection
Composition: Trastuzumab Injection 150mg
International Trade Name: Herceptin®

Canmab 150 is a high-quality Trastuzumab 150mg Injection, a biosimilar equivalent of the internationally recognized HER2-targeted monoclonal antibody marketed under the brand name Herceptin®. Manufactured in WHO-GMP certified facilities under stringent biologics production standards, Canmab 150 Injection is supplied by trusted pharmaceutical exporters from India to support global oncology and breast cancer treatment programs.

Trastuzumab is a humanized monoclonal antibody that selectively binds to the HER2 receptor, inhibiting HER2-mediated signaling pathways and inducing antibody-dependent cellular cytotoxicity (ADCC). Canmab 150 Injection is primarily indicated for the treatment of HER2-positive breast cancer and HER2-positive gastric or gastroesophageal junction adenocarcinoma, administered alone or in combination with chemotherapy as per established treatment protocols.

High-ranking search keywords include: Trastuzumab 150mg injection, Canmab 150 injection, Herceptin biosimilar, trastuzumab price, HER2 positive breast cancer treatment, trastuzumab exporter India, oncology monoclonal antibody supplier, and breast cancer biologic manufacturer India.

Canmab 150 Trastuzumab Injection is manufactured under strict GMP and cold-chain controlled conditions, ensuring molecular integrity, consistent potency, and long-term stability. The injection is supplied in secure, export-grade packaging with complete regulatory and cold-chain documentation, making it suitable for hospital oncology centers, cancer institutes, government tenders, specialty distributors, and international pharmaceutical supply chains.

Reditux 500mg Injection
Composition: Rituximab Injection 500mg
International Trade Name: Rituxan®

Reditux 500 is a high-quality Rituximab 500mg Injection, a biosimilar of the internationally renowned anti-CD20 monoclonal antibody marketed under the brand name Rituxan®. Manufactured in WHO-GMP certified facilities, Reditux Injection is supplied by trusted pharmaceutical exporters from India to support global oncology, hematology, and immunology treatment programs.

Rituximab is a chimeric monoclonal antibody that selectively targets the CD20 antigen expressed on B-lymphocytes, leading to B-cell lysis through complement-dependent cytotoxicity (CDC), antibody-dependent cell-mediated cytotoxicity (ADCC), and induction of apoptosis. Reditux 500mg Injection is primarily indicated for the treatment of non-Hodgkin’s lymphoma (NHL), chronic lymphocytic leukemia (CLL), and is also widely used in autoimmune disorders such as rheumatoid arthritis in combination therapy.

High-ranking search keywords include: Rituximab 500mg injection, Reditux 500 injection, Rituxan biosimilar, rituximab price, non-Hodgkin lymphoma treatment, CD20 monoclonal antibody, oncology biologics exporter India, and biosimilar manufacturer India.

Reditux 500 Rituximab Injection is manufactured under stringent GMP and biologics quality standards, ensuring consistent efficacy, safety, and long-term stability. The injection is supplied in secure, cold-chain compliant, export-grade packaging with complete regulatory documentation, making it suitable for oncology and hematology centers, infusion clinics, government supply programs, and international pharmaceutical distributors.

Ujvira 160mg Injection
Composition: Trastuzumab Emtansine Injection 160mg
International Trade Name: Kadcyla®

Ujvira 160 is a high-quality Trastuzumab Emtansine 160mg Injection, a biosimilar equivalent of the internationally recognized HER2-targeted antibody–drug conjugate (ADC) marketed under the brand name Kadcyla®. Manufactured in WHO-GMP certified facilities, Ujvira Injection is supplied by trusted pharmaceutical exporters from India to support advanced global oncology treatment programs, particularly in HER2-positive breast cancer.

Trastuzumab emtansine (T-DM1) combines the HER2-targeting monoclonal antibody trastuzumab with the potent cytotoxic agent DM1 (emtansine), enabling targeted delivery of chemotherapy directly to HER2-overexpressing cancer cells. Ujvira 160mg Injection is primarily indicated for the treatment of HER2-positive metastatic or early breast cancer, especially in patients previously treated with trastuzumab and taxane-based therapy.

High-ranking search keywords include: Trastuzumab emtansine 160mg injection, Ujvira 160 injection, Kadcyla biosimilar, T-DM1 price, HER2-positive breast cancer treatment, ADC oncology injection, biologics exporter India, and anticancer monoclonal antibody manufacturer India.

Ujvira 160 Trastuzumab Emtansine Injection is manufactured under stringent GMP and biologics quality standards, ensuring consistent efficacy, safety, and long-term stability. The injection is supplied in secure, cold-chain compliant, export-grade packaging with complete regulatory documentation, making it suitable for oncology infusion centers, tertiary care hospitals, government cancer programs, and international pharmaceutical distributors.

Vivitra 150mg Injection
Composition: Trastuzumab Injection 150mg
International Trade Name: Herceptin®

Vivitra 150 is a high-quality Trastuzumab 150mg Injection, a biosimilar equivalent of the internationally recognized HER2-targeted monoclonal antibody marketed under the brand name Herceptin®. Manufactured in WHO-GMP certified facilities, Vivitra Injection is supplied by trusted pharmaceutical exporters from India to support global oncology treatment programs, particularly in HER2-positive cancers.

Trastuzumab is a humanized monoclonal antibody that selectively binds to the HER2/neu receptor, inhibiting tumor cell proliferation and mediating antibody-dependent cell-mediated cytotoxicity (ADCC). Vivitra 150mg Injection is primarily indicated for the treatment of HER2-positive breast cancer (early-stage and metastatic) and HER2-positive gastric or gastroesophageal junction adenocarcinoma, either as monotherapy or in combination chemotherapy regimens.

High-ranking search keywords include: Trastuzumab 150mg injection, Vivitra 150 injection, Herceptin biosimilar, trastuzumab price, HER2-positive breast cancer treatment, monoclonal antibody oncology injection, biologics exporter India, and biosimilar manufacturer India.

Vivitra 150 Trastuzumab Injection is manufactured under stringent GMP and biologics quality standards, ensuring consistent efficacy, safety, and long-term stability. The injection is supplied in secure, cold-chain compliant, export-grade packaging with complete regulatory documentation, making it suitable for oncology infusion centers, tertiary care hospitals, government cancer programs, and international pharmaceutical distributors.

Mabtas RA 500mg Injection
Composition: Rituximab Injection 500mg
International Trade Name: Rituxan®

Mabtas RA 500 is a high-quality Rituximab 500mg Injection, a biosimilar equivalent of the internationally recognized anti-CD20 monoclonal antibody marketed under the brand name Rituxan®. Manufactured in WHO-GMP certified facilities, Mabtas RA Injection is supplied by trusted pharmaceutical exporters from India to support global oncology, hematology, and autoimmune disease treatment programs.

Rituximab is a chimeric monoclonal antibody that selectively targets the CD20 antigen on B-lymphocytes, leading to B-cell depletion through complement-dependent cytotoxicity (CDC), antibody-dependent cell-mediated cytotoxicity (ADCC), and induction of apoptosis. Mabtas RA 500mg Injection is primarily indicated for the treatment of non-Hodgkin’s lymphoma (NHL), chronic lymphocytic leukemia (CLL), and rheumatoid arthritis (RA) in combination with methotrexate, as well as other autoimmune indications.

High-ranking search keywords include: Rituximab 500mg injection, Mabtas RA 500 injection, Rituxan biosimilar, rituximab price, CD20 monoclonal antibody therapy, NHL and RA treatment, biologics exporter India, and biosimilar manufacturer India.

Mabtas RA 500 Rituximab Injection is manufactured under stringent GMP and biologics quality standards, ensuring consistent efficacy, safety, and long-term stability. The injection is supplied in secure, cold-chain compliant, export-grade packaging with complete regulatory documentation, making it suitable for oncology infusion centers, rheumatology clinics, hospitals, government supply programs, and international pharmaceutical distributors.

Eleftha 375mg Injection
Composition: Trastuzumab Injection 375mg
International Trade Name: Herceptin®

Eleftha 375 is a high-quality Trastuzumab 375mg Injection, a biosimilar equivalent of the internationally recognized HER2-targeted monoclonal antibody marketed under the brand name Herceptin®. Manufactured in WHO-GMP certified facilities, Eleftha Injection is supplied by trusted pharmaceutical exporters from India to support global oncology treatment programs, particularly in HER2-positive cancers.

Trastuzumab is a humanized monoclonal antibody that selectively binds to the HER2/neu receptor, inhibiting tumor cell proliferation and mediating antibody-dependent cell-mediated cytotoxicity (ADCC). Eleftha 375mg Injection is primarily indicated for the treatment of HER2-positive breast cancer (early-stage and metastatic) and HER2-positive gastric or gastroesophageal junction adenocarcinoma, either as monotherapy or in combination chemotherapy regimens.

High-ranking search keywords include: Trastuzumab 375mg injection, Eleftha 375 injection, Herceptin biosimilar, trastuzumab price, HER2-positive breast cancer treatment, monoclonal antibody oncology injection, biologics exporter India, and biosimilar manufacturer India.

Eleftha 375 Trastuzumab Injection is manufactured under stringent GMP and biologics quality standards, ensuring consistent efficacy, safety, and long-term stability. The injection is supplied in secure, cold-chain compliant, export-grade packaging with complete regulatory documentation, making it suitable for oncology infusion centers, tertiary care hospitals, government cancer programs, and international pharmaceutical distributors.

Samtica 250 mg – Abiraterone Acetate 250 mg Tablets (Zytiga)

Samtica 250 mg contains Abiraterone Acetate 250 mg, a well-established medication used in the treatment of metastatic castration-resistant prostate cancer (mCRPC) and metastatic hormone-sensitive prostate cancer, as prescribed by an oncologist.

Abiraterone Acetate works by blocking androgen production, which helps slow the growth and spread of prostate cancer cells. Internationally, Abiraterone is widely known under the reference brand Zytiga, making Samtica a trusted therapeutic option in oncology care.

Key Benefits

• Contains Abiraterone Acetate 250 mg

• Used in advanced prostate cancer treatment

• Helps reduce androgen levels that fuel cancer growth

• Widely prescribed and clinically proven

• Oral tablet for convenient administration

Product Details

• Brand Name: Samtica

• Generic Name: Abiraterone Acetate

• Strength: 250 mg

• Dosage Form: Tablets

• Reference Brand: Zytiga

• Indication: Prostate Cancer (as prescribed)

Keywords

Samtica 250 mg, Abiraterone Acetate 250 mg tablets, Zytiga alternative, buy Abiraterone Acetate, prostate cancer tablets, Abiraterone 250 mg, oncology medicines Abiraterone.

Why Choose This Product?

• Manufactured by licensed pharmaceutical companies

• Quality-assured and export-ready

• Cost-effective alternative to branded Zytiga

• Trusted by healthcare providers globally

FAQs

Q1. What is Samtica 250 mg used for?
It is used for the treatment of advanced prostate cancer, under medical supervision.

Q2. Is Samtica the same as Zytiga?
Samtica contains the same active ingredient, Abiraterone Acetate, as Zytiga.

Q3. How should Abiraterone be taken?
It is usually taken on an empty stomach, along with prednisone, as directed by a doctor.

Q4. Is this product genuine?
Yes, it is sourced from licensed manufacturers with proper quality documentation.

Q5. Do you supply internationally?
Yes, international supply is available, subject to local regulations.

Indenza Enzalutamide Capsules 40 mg (Xtandi)

Indenza Enzalutamide Capsules 40 mg contain enzalutamide, an androgen receptor inhibitor used in the management of prostate cancer. Enzalutamide works by blocking the effects of androgens (male hormones), which play a key role in the growth and progression of prostate cancer cells.

These capsules are commonly prescribed for the treatment of metastatic and non-metastatic castration-resistant prostate cancer (CRPC), as well as metastatic hormone-sensitive prostate cancer (mHSPC), as directed by a healthcare professional.

Key Features:

• Contains Enzalutamide 40 mg per capsule

• Oral capsule formulation for convenient administration

• Helps inhibit androgen receptor signaling

• Manufactured in compliance with quality and safety standards

Dosage & Administration:
To be taken orally as prescribed by a physician. Dosage and duration depend on the patient’s medical condition and response to therapy.

Storage:
Store at room temperature, away from moisture and direct sunlight. Keep out of reach of children.

Prescription Status:
Prescription medicine only. Use under medical supervision.

Optimized Product Description

Product Title: Azacytin 200mg | Azacitidine for Injection | Professional Strength Generic Vidaza

Description:

Elevate your clinical outcomes with Azacytin 200mg, a high-strength Azacitidine for Injection formulation. Designed for precision dosing in oncology settings, Azacytin 200mg serves as a reliable, cost-effective alternative to Vidaza. This antimetabolite is specifically engineered for the treatment of Myelodysplastic Syndromes (MDS) subtypes and Acute Myeloid Leukemia (AML) where higher concentration per vial is required.

By inhibiting DNA methyltransferase, Azacytin restores normal growth to bone marrow cells. This 200mg lyophilized powder ensures streamlined preparation for healthcare providers handling high-volume treatment cycles.

Product Specifications:

• Strength: 200mg Azacitidine per vial.

• Usage: Subcutaneous (SC) or Intravenous (IV) administration after reconstitution.

• Indication: FIGO/WHO classified Myelodysplastic Syndromes and AML.

• Storage: Controlled room temperature ($25^\circ\text{C}$); excursions permitted between $15^\circ\text{C}$ and $30^\circ\text{C}$.

Secure Azacytin 200mg (Azacitidine for Injection). The high-potency generic for Vidaza used in MDS & AML therapy. Quality-assured oncology medication.


Primary Keywords: Azacytin 200mg, Azacitidine for Injection 200mg, Azacitidine 200mg Vial, High-dose Azacitidine.

• Secondary Keywords: Oncology injections, Vidaza 200mg alternative, MDS chemotherapy 200mg, Azacitidine lyophilized powder.

• Long-tail Keywords: Buy Azacytin 200mg online, Azacitidine 200mg price for injection, Azacytin 200mg manufacturer specifications.

Abirakast 500 mg (Abiraterone Acetate 500 mg Tablets) – Advanced Prostate Cancer Treatment

Abirakast Abiraterone Acetate 500 mg Tablets are a highly effective and widely used medication for the treatment of advanced prostate cancer. Formulated with Abiraterone Acetate, this therapy works by reducing androgen production in the body, which helps slow down the growth and spread of cancer cells.

As a registered pharmacist from India, I ensure the supply of genuine Abirakast 500 mg tablets with proper storage, handling, and full pharmaceutical compliance—making it a trusted choice for hospitals, distributors, and healthcare providers worldwide.

What is Abirakast 500 mg (Abiraterone Acetate)?

Abirakast 500 mg contains Abiraterone Acetate 500 mg, a potent anti-cancer medication used for:

• Metastatic Castration-Resistant Prostate Cancer (mCRPC)

• Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)

It is commonly prescribed along with corticosteroids such as prednisone to enhance treatment effectiveness.

Abiraterone Acetate 500 mg Uses

Key uses of Abiraterone Acetate 500 mg tablets include:

• Reducing androgen (testosterone) production

• Slowing cancer progression

• Supporting long-term disease management

• Improving overall survival outcomes

How Abiraterone Works

Abiraterone Acetate belongs to a class of drugs known as androgen biosynthesis inhibitors. It works by:

• Blocking the CYP17 enzyme responsible for androgen production

• Reducing hormone levels that fuel prostate cancer

• Helping control tumor growth and spread

Dosage & Administration

• Take Abirakast 500 mg tablets exactly as prescribed by a healthcare professional

• Usually taken once daily on an empty stomach

• Swallow whole with water; do not crush or chew

Available Strengths & Packaging

Abiraterone is available in different strengths for flexible treatment:

• Abirakast 250 mg tablets

• Abirakast 500 mg tablets

Packaging options may vary depending on treatment requirements and supply.

Why Choose Us?

As a registered pharmacist and pharmaceutical exporter from India, we provide:

• Genuine and quality-assured oncology medicines

• Competitive pricing for bulk and export orders

• Proper storage and handling compliance

• Secure packaging and reliable international shipping

• Complete export documentation

• Professional customer support

Conclusion

Abirakast Abiraterone Acetate 500 mg Tablets are a trusted and effective solution for managing advanced prostate cancer. With assured quality, expert handling, and reliable global supply, we are committed to supporting healthcare providers and distributors worldwide.

For pricing, bulk orders, or export inquiries, feel free to contact us.

Eltrombo 50 mg (Eltrombopag Olamine Tablets 50 mg) – Effective Platelet Count Therapy

Eltrombo 50 mg Eltrombopag Olamine Tablets 50 mg is a clinically trusted medication used for the treatment of low platelet count (thrombocytopenia). It contains Eltrombopag Olamine, a thrombopoietin receptor agonist that helps stimulate platelet production and maintain healthy platelet levels.

As a registered pharmacist from India, I ensure the supply of genuine Eltrombo 50 mg tablets with proper storage, handling, and full pharmaceutical compliance—making it a reliable choice for hospitals, distributors, and healthcare providers worldwide.

What is Eltrombo 50 mg (Eltrombopag Olamine)?

Eltrombo 50 mg contains Eltrombopag Olamine 50 mg, which is commonly prescribed for:

• Chronic Immune Thrombocytopenia (ITP)

• Aplastic Anemia

• Thrombocytopenia associated with chronic hepatitis C

It is used to increase platelet levels and reduce the risk of bleeding complications.

Eltrombopag 50 mg Uses

Key uses of Eltrombopag 50 mg tablets include:

• Stimulating platelet production in the bone marrow

• Reducing the risk of bleeding

• Supporting treatment of chronic blood disorders

• Maintaining stable platelet counts

How Eltrombopag Works

Eltrombopag Olamine works by:

• Activating thrombopoietin receptors

• Increasing platelet production

• Helping restore normal platelet levels

Dosage & Administration

• Take Eltrombo 50 mg tablets exactly as prescribed by a healthcare professional

• Usually taken once daily on an empty stomach

• Avoid taking with dairy products or mineral supplements close to dosing

Available Strengths

Eltrombopag tablets are available in multiple strengths:

• 25 mg

• 50 mg

• 75 mg

Why Choose Us?

As a registered pharmacist and pharmaceutical exporter from India, we offer:

• Genuine and quality-assured medicines

• Competitive pricing for bulk and export orders

• Proper storage and handling compliance

• Secure packaging and reliable global shipping

• Complete export documentation

• Professional customer support

Conclusion

Eltrombo 50 mg (Eltrombopag Olamine Tablets 50 mg) is a trusted and effective solution for managing low platelet counts and related conditions. With assured quality, expert handling, and dependable global supply, we are committed to supporting healthcare providers and distributors worldwide.

For pricing, bulk orders, or export inquiries, feel free to contact us.

Indenza 160 (Enzalutamide Capsules 160 mg) – Advanced Therapy for Prostate Cancer

Indenza 160 Enzalutamide Capsules 160 mg is a highly effective hormonal therapy used in the treatment of advanced prostate cancer. It contains Enzalutamide, an androgen receptor inhibitor that helps block the effect of male hormones (androgens), which are responsible for the growth of prostate cancer cells.

As a registered pharmacist from India, I ensure the supply of genuine Indenza 160 mg capsules with proper storage, handling, and full pharmaceutical compliance—making it a trusted choice for hospitals, distributors, and healthcare providers worldwide.

What is Indenza 160 (Enzalutamide 160 mg)?

Indenza 160 mg contains Enzalutamide 160 mg, which is commonly prescribed for:

• Metastatic Castration-Resistant Prostate Cancer (mCRPC)

• Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)

• Non-metastatic castration-resistant prostate cancer

It is a targeted hormonal therapy designed to slow cancer progression.

Enzalutamide 160 mg Uses

Key uses of Enzalutamide 160 mg capsules include:

• Blocking androgen receptors in prostate cancer cells

• Slowing tumor growth and spread

• Supporting long-term disease control

• Improving survival outcomes

How Enzalutamide Works

Enzalutamide belongs to a class of drugs called androgen receptor inhibitors. It works by:

• Preventing androgens from binding to cancer cells

• Blocking signals that promote tumor growth

• Reducing the progression of prostate cancer

Dosage & Administration

• Take Indenza 160 mg capsules exactly as prescribed by a healthcare professional

• Usually taken once daily, with or without food

• Swallow capsules whole with water

Available Strengths

Enzalutamide capsules are available in different strengths depending on treatment needs:

• 40 mg

• 80 mg

• 160 mg

Why Choose Us?

As a registered pharmacist and pharmaceutical exporter from India, we provide:

• Genuine and quality-assured oncology medicines

• Competitive pricing for bulk and export orders

• Proper storage and handling compliance

• Secure packaging and reliable international shipping

• Complete export documentation

• Professional customer support

Conclusion

Indenza 160 (Enzalutamide Capsules 160 mg) is a trusted and effective hormonal therapy for advanced prostate cancer. With assured quality, expert handling, and dependable global supply, we are committed to supporting healthcare providers and distributors worldwide.

For pricing, bulk orders, or export inquiries, feel free to contact us.

Erdanat 4 mg (Erdafitinib 4 mg Tablet) – Targeted Therapy for Advanced Cancer

Erdanat 4 mg Erdafitinib 4 mg Tablet is a highly effective targeted anti-cancer medication used in the treatment of advanced or metastatic urothelial carcinoma (bladder cancer). It contains Erdafitinib, a fibroblast growth factor receptor (FGFR) inhibitor that works by blocking cancer cell growth at the molecular level.

As a registered pharmacist from India, I ensure the supply of genuine Erdanat 4 mg tablets with proper storage, handling, and full pharmaceutical compliance—making it a trusted choice for hospitals, distributors, and healthcare providers worldwide.

What is Erdanat 4 mg (Erdafitinib)?

Erdanat 4 mg contains Erdafitinib 4 mg, which is primarily prescribed for:

• Advanced or Metastatic Urothelial Carcinoma (Bladder Cancer)
• Patients with specific FGFR genetic mutations
• Cases where prior chemotherapy has not been effective

It is a precision-targeted therapy designed for personalized cancer treatment.

Erdafitinib 4 mg Uses

Key uses of Erdafitinib 4 mg tablets include:

• Blocking cancer cell growth driven by FGFR mutations
• Slowing tumor progression
• Supporting targeted treatment strategies
• Improving disease control in advanced cases

How Erdafitinib Works

Erdafitinib belongs to the class of FGFR inhibitors. It works by:

• Blocking fibroblast growth factor receptors (FGFR)
• Interrupting signals that promote tumor growth
• Reducing cancer cell proliferation

Dosage & Administration

• Take Erdanat 4 mg tablets exactly as prescribed by a healthcare professional
• Usually taken once daily, with or without food
• Swallow whole with water; do not crush or chew

Available Strengths

Erdafitinib tablets are available in different strengths:

• 3 mg
• 4 mg
• 5 mg

Why Choose Us?

As a registered pharmacist and pharmaceutical exporter from India, we provide:

• Genuine and quality-assured oncology medicines
• Competitive pricing for bulk and export orders
• Proper storage and handling compliance
• Secure packaging and reliable global shipping
• Complete export documentation
• Professional customer support

Conclusion

Erdanat 4 mg (Erdafitinib 4 mg Tablet) is a trusted and effective targeted therapy for advanced bladder cancer. With assured quality, expert handling, and dependable global supply, we are committed to supporting healthcare providers and distributors worldwide.

Apiedge 5mg Tablet
Composition: Apixaban Tablets 5mg
International Trade Name: Eliquis®

Apiedge 5 is a high-quality Apixaban 5mg Tablet, a generic equivalent of the internationally recognized direct oral anticoagulant (DOAC) Eliquis®. Manufactured in WHO-GMP certified facilities, Apiedge 5 Tablets are supplied by trusted pharmaceutical exporters from India to support global cardiovascular care and thrombosis management programs.

Apixaban is a selective Factor Xa inhibitor that prevents thrombin generation and clot formation without the need for routine coagulation monitoring. Apiedge 5 Tablets are primarily indicated for the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation, treatment and prevention of deep vein thrombosis (DVT) and pulmonary embolism (PE), and post-operative thromboprophylaxis following hip or knee replacement surgery.

High-ranking search keywords include: Apixaban 5mg tablet, Apiedge 5 tablet, Eliquis generic tablet, apixaban price, factor Xa inhibitor, anticoagulant tablet, apixaban exporter India, cardiovascular drug manufacturer India, and DOAC tablet supplier.

Apiedge 5 Apixaban Tablets are manufactured under strict GMP quality standards, ensuring consistent potency, accurate dosing, and long-term stability. The tablets are supplied in secure, export-grade packaging with appropriate regulatory documentation, making them suitable for hospital cardiology departments, internal medicine clinics, specialty pharmacies, and international pharmaceutical distributors.

Nintedoc 150 Soft Gelatin Capsule
Composition: Nintedanib Soft Gelatin Capsules 150mg
International Trade Name: Ofev® / Vargatef®

Nintedoc 150 is a high-quality Nintedanib 150mg Soft Gelatin Capsule, a generic equivalent of the internationally recognized tyrosine kinase inhibitor marketed as Ofev® and Vargatef®. Manufactured in WHO-GMP certified facilities, Nintedoc 150 Capsules are supplied by trusted pharmaceutical exporters from India to support global pulmonology and oncology treatment programs.

Nintedanib is a small-molecule tyrosine kinase inhibitor that targets multiple growth factor receptors, including VEGFR, FGFR, and PDGFR, thereby inhibiting pathways involved in fibrosis progression and tumor angiogenesis. Nintedoc 150 Capsules are primarily indicated for the treatment of idiopathic pulmonary fibrosis (IPF), other chronic fibrosing interstitial lung diseases (ILDs) with a progressive phenotype, and non-small cell lung cancer (NSCLC) in specific clinical settings.

High-ranking search keywords include: Nintedanib 150mg capsule, Nintedoc 150 capsule, Ofev generic capsule, Vargatef generic capsule, nintedanib price, idiopathic pulmonary fibrosis treatment, ILD therapy, nintedanib exporter India, and tyrosine kinase inhibitor capsule supplier.

Nintedoc 150 Nintedanib Soft Gelatin Capsules are manufactured under stringent GMP quality standards, ensuring consistent potency, accurate dosing, and long-term stability. The capsules are supplied in secure, export-grade packaging with appropriate regulatory documentation, making them suitable for pulmonology clinics, oncology centers, specialty pharmacies, and international pharmaceutical distributors.

Nintedoc 150 Soft Gelatin Capsule
Composition: Nintedanib Soft Gelatin Capsules 150mg
International Trade Name: Ofev® / Vargatef®

Nintedoc 150 is a high-quality Nintedanib 150mg Soft Gelatin Capsule, a generic equivalent of the internationally recognized tyrosine kinase inhibitor marketed as Ofev® and Vargatef®. Manufactured in WHO-GMP certified facilities, Nintedoc 150 Capsules are supplied by trusted pharmaceutical exporters from India to support global pulmonology and oncology treatment programs.

Nintedanib is a small-molecule tyrosine kinase inhibitor that targets multiple growth factor receptors, including VEGFR, FGFR, and PDGFR, thereby inhibiting pathways involved in fibrosis progression and tumor angiogenesis. Nintedoc 150 Capsules are primarily indicated for the treatment of idiopathic pulmonary fibrosis (IPF), other chronic fibrosing interstitial lung diseases (ILDs) with a progressive phenotype, and non-small cell lung cancer (NSCLC) in specific clinical settings.

High-ranking search keywords include: Nintedanib 150mg capsule, Nintedoc 150 capsule, Ofev generic capsule, Vargatef generic capsule, nintedanib price, idiopathic pulmonary fibrosis treatment, ILD therapy, nintedanib exporter India, and tyrosine kinase inhibitor capsule supplier.

Nintedoc 150 Nintedanib Soft Gelatin Capsules are manufactured under stringent GMP quality standards, ensuring consistent potency, accurate dosing, and long-term stability. The capsules are supplied in secure, export-grade packaging with appropriate regulatory documentation, making them suitable for pulmonology clinics, oncology centers, specialty pharmacies, and international pharmaceutical distributors.

Azel Enzalutamide 80mg Xtandi Capsule is a trusted anti-androgen therapy used in advanced and metastatic prostate cancer treatment. This enzalutamide capsule works by blocking androgen receptor signaling, helping slow cancer progression and improve survival outcomes. Patients and global buyers often search for enzalutamide 80 mg, enzalutamide capsule uses, Xtandi generic, enzalutamide price, and enzalutamide cost in India when comparing therapy options. Known for its clinical effectiveness, Azel Enzalutamide is widely used in hormone-resistant prostate cancer management, with monitored use to manage potential enzalutamide side effects and ensure optimal treatment results.

Trasturel 150mg Injection
Composition: Trastuzumab Injection 150mg
International Trade Name: Herceptin®

Trasturel 150 is a high-quality Trastuzumab 150mg Injection, a biosimilar/generic equivalent of the internationally recognized HER2-targeted monoclonal antibody marketed under the brand name Herceptin®. Manufactured in WHO-GMP certified facilities under stringent biologics production standards, Trasturel 150 Injection is supplied by trusted pharmaceutical exporters from India to support global oncology and breast cancer treatment programs.

Trastuzumab is a humanized monoclonal antibody that selectively binds to the HER2 receptor, inhibiting HER2-mediated signaling pathways and inducing antibody-dependent cellular cytotoxicity (ADCC). Trasturel 150 Injection is primarily indicated for the treatment of HER2-positive breast cancer and HER2-positive gastric or gastroesophageal junction adenocarcinoma, administered as monotherapy or in combination with chemotherapy according to established treatment protocols.

High-ranking search keywords include: Trastuzumab 150mg injection, Trasturel 150 injection, Herceptin biosimilar, trastuzumab price, HER2 positive breast cancer treatment, trastuzumab exporter India, oncology monoclonal antibody supplier, and breast cancer biologic manufacturer India.

Trasturel 150 Trastuzumab Injection is manufactured under strict GMP and cold-chain controlled conditions, ensuring molecular integrity, consistent potency, and long-term stability. The injection is supplied in secure, export-grade packaging with complete regulatory and cold-chain documentation, making it suitable for hospital oncology centers, cancer institutes, government tenders, specialty distributors, and international pharmaceutical supply chains.

Eltrombo 25 mg (Eltrombopag Olamine Tablets 25 mg) – Platelet Count Management Therapy

Eltrombo 25 mg Eltrombopag Olamine Tablets 25 mg is a clinically proven medication used to treat conditions associated with low platelet counts (thrombocytopenia). It contains Eltrombopag Olamine, a thrombopoietin receptor agonist that helps stimulate platelet production in the bone marrow.

As a registered pharmacist from India, I ensure the supply of genuine Eltrombo 25 mg tablets with proper storage, handling, and full pharmaceutical compliance—making it a trusted choice for hospitals, distributors, and healthcare providers worldwide.

What is Eltrombo 25 mg (Eltrombopag Olamine)?

Eltrombo 25 mg contains Eltrombopag Olamine 25 mg, which is commonly prescribed for:

• Chronic Immune Thrombocytopenia (ITP)

• Aplastic Anemia

• Thrombocytopenia in patients with chronic hepatitis C

It is used to increase platelet levels and reduce the risk of bleeding.

Eltrombopag 25 mg Uses

Key uses of Eltrombopag 25 mg tablets include:

• Stimulating platelet production

• Reducing bleeding risk

• Supporting treatment in chronic blood disorders

• Improving overall platelet stability

How Eltrombopag Works

Eltrombopag Olamine works by:

• Activating thrombopoietin receptors in the bone marrow

• Increasing platelet production

• Helping maintain healthy platelet levels

Dosage & Administration

• Take Eltrombo 25 mg tablets exactly as prescribed by a healthcare professional

• Usually taken once daily on an empty stomach

• Avoid taking with calcium-rich foods or supplements close to dosing

Available Strengths

Eltrombopag tablets are available in different strengths:

• 25 mg

• 50 mg

• 75 mg

Why Choose Us?

As a registered pharmacist and pharmaceutical exporter from India, we provide:

• Genuine and quality-assured medicines

• Competitive pricing for bulk and export orders

• Proper storage and handling compliance

• Secure packaging and reliable worldwide shipping

• Complete export documentation

• Professional customer support

Conclusion

Eltrombo 25 mg (Eltrombopag Olamine Tablets 25 mg) is a trusted and effective treatment for managing low platelet counts and related conditions. With assured quality, expert handling, and dependable global supply, we are committed to supporting healthcare providers and distributors worldwide.

For pricing, bulk orders, or export inquiries, feel free to contact us.

Inlybest 5 mg (Axitinib Tablets 5 mg) – Targeted Therapy for Kidney Cancer

Inlybest 5 mg Axitinib Tablets 5 mg is a highly effective targeted anti-cancer medication used in the treatment of advanced renal cell carcinoma (kidney cancer). It contains Axitinib, a potent tyrosine kinase inhibitor that works by blocking tumor growth and reducing blood supply to cancer cells.

As a registered pharmacist from India, I ensure the supply of genuine Inlybest 5 mg tablets with proper storage, handling, and full pharmaceutical compliance—making it a trusted choice for hospitals, distributors, and healthcare providers worldwide.

What is Inlybest 5 mg (Axitinib)?

Inlybest 5 mg contains Axitinib 5 mg, which is primarily prescribed for:

• Advanced Renal Cell Carcinoma (Kidney Cancer)

• Patients who have not responded to prior therapy

It is a targeted therapy designed to slow cancer progression and improve treatment outcomes.

Axitinib 5 mg Uses

Key uses of Axitinib 5 mg tablets include:

• Inhibiting tumor growth

• Blocking angiogenesis (formation of blood vessels supplying tumors)

• Slowing the spread of cancer cells

• Supporting long-term cancer management

How Axitinib Works

Axitinib belongs to the class of tyrosine kinase inhibitors (TKIs). It works by:

• Blocking specific enzymes responsible for tumor growth

• Preventing blood supply to cancer cells

• Reducing tumor progression

Dosage & Administration

• Take Inlybest 5 mg tablets exactly as prescribed by a healthcare professional

• Usually taken twice daily, with or without food

• Swallow whole with water; do not crush or chew

Available Strengths

Axitinib tablets are available in multiple strengths:

• 1 mg

• 3 mg

• 5 mg

Why Choose Us?

As a registered pharmacist and pharmaceutical exporter from India, we provide:

• Genuine and quality-assured oncology medicines

• Competitive pricing for bulk and export orders

• Proper storage and handling compliance

• Secure packaging and reliable global shipping

• Complete export documentation

• Professional customer support

Conclusion

Inlybest 5 mg (Axitinib Tablets 5 mg) is a trusted and effective targeted therapy for kidney cancer treatment. With assured quality, expert handling, and dependable global supply, we are committed to supporting healthcare providers and distributors worldwide.

For pricing, bulk orders, or export inquiries, feel free to contact us.

Domvel 60 mg PFS Injection
Composition: Denosumab 60 mg / 1 ml Pre-Filled Syringe
International Trade Name: Prolia / Xgeva

Domvel 60 mg PFS is a premium Denosumab injection supplied by Shivanta Impex, a trusted pharmaceutical exporter from India. This formulation contains Denosumab 60 mg in a 1 ml pre-filled syringe, a fully human monoclonal antibody internationally recognized under the brand names Prolia and Xgeva. It is widely used in the treatment of osteoporosis, bone loss associated with cancer therapy, and prevention of skeletal-related events in patients with bone metastases.

Domvel 60 mg injection, Denosumab 60 mg PFS, Prolia generic injection, Xgeva generic injection, Denosumab exporter India, Denosumab bulk supplier, oncology and bone health Denosumab injection, and Denosumab manufacturer India.

Manufactured under stringent GMP standards, Domvel 60 mg PFS ensures consistent quality, precise dosage, and sterile, export-grade packaging, making it suitable for global pharmaceutical distribution and specialty care markets.

Adrim 50 mg Injection
Composition: Doxorubicin 50 mg Injection
International Trade Name: Doxorubicin

Adrim 50 mg is a premium Doxorubicin injection supplied by Shivanta Impex, a trusted pharmaceutical exporter from India. This formulation contains Doxorubicin 50 mg, an anthracycline antineoplastic agent widely recognized for its efficacy in treating breast cancer, leukemia, lymphoma, sarcomas, and other solid tumors.

Adrim 50 mg injection, Doxorubicin 50 mg injection, Doxorubicin generic injection, Doxorubicin exporter India, Doxorubicin bulk supplier, oncology Doxorubicin injection, and Doxorubicin manufacturer India.

Manufactured under stringent GMP standards, Adrim 50 mg ensures consistent quality, accurate concentration, and sterile, export-grade packaging, making it suitable for global pharmaceutical distribution and oncology markets.

Versavo 400 Solution for Infusion
Composition: Bevacizumab Solution for Infusion 400mg
International Trade Name: Avastin®

Versavo 400 is a high-quality Bevacizumab 400mg Solution for Infusion, a biosimilar/generic equivalent of the internationally recognized anti-VEGF monoclonal antibody marketed under the brand name Avastin®. Manufactured in WHO-GMP certified facilities under stringent biologics production standards, Versavo 400 is supplied by trusted pharmaceutical exporters from India to support global oncology treatment programs.

Bevacizumab is a recombinant humanized monoclonal antibody that inhibits vascular endothelial growth factor (VEGF), thereby suppressing tumor angiogenesis and reducing blood supply to cancer cells. Versavo 400 Solution for Infusion is indicated for the treatment of multiple malignancies, including colorectal cancer, non-small cell lung cancer (NSCLC), ovarian cancer, cervical cancer, renal cell carcinoma, and glioblastoma, in combination with standard chemotherapy regimens as per clinical guidelines.

High-ranking search keywords include: Bevacizumab 400mg infusion, Versavo 400 infusion, Avastin biosimilar, bevacizumab price, anti-VEGF therapy, oncology monoclonal antibody exporter India, bevacizumab supplier, and cancer biologics manufacturer India.

Versavo 400 Bevacizumab Solution for Infusion is manufactured under strict GMP and cold-chain controlled conditions, ensuring molecular integrity, consistent potency, and long-term stability. The infusion is supplied in secure, export-grade packaging with complete regulatory and cold-chain documentation, making it suitable for hospital oncology centers, cancer institutes, government tenders, specialty distributors, and international pharmaceutical supply chains.

Perzea 420mg Injection
Composition: Pertuzumab Injection 420mg
International Trade Name: Perjeta®

Perzea 420 is a high-quality Pertuzumab 420mg Injection, a biosimilar/generic equivalent of the internationally recognized HER2-targeted monoclonal antibody marketed under the brand name Perjeta®. Manufactured in WHO-GMP certified facilities following stringent biologics manufacturing standards, Perzea 420 Injection is supplied by trusted pharmaceutical exporters from India to support global oncology and breast cancer treatment programs.

Pertuzumab is a humanized monoclonal antibody that targets the HER2 receptor, specifically inhibiting HER2 dimerization with other HER family receptors. This dual HER2 blockade mechanism significantly reduces tumor cell proliferation and survival. Perzea 420 Injection is primarily indicated for the treatment of HER2-positive breast cancer, including metastatic breast cancer and early-stage breast cancer, in combination with trastuzumab and chemotherapy as per established treatment protocols.

High-ranking search keywords include: Pertuzumab 420mg injection, Perzea 420 injection, Perjeta biosimilar, pertuzumab price, HER2 positive breast cancer treatment, pertuzumab exporter India, oncology monoclonal antibody supplier, and breast cancer biologic manufacturer India.

Perzea 420 Pertuzumab Injection is manufactured under strict GMP and cold-chain controlled conditions, ensuring molecular integrity, clinical efficacy, and long-term stability. The injection is supplied in secure, export-grade packaging with complete regulatory and cold-chain documentation, making it suitable for hospital oncology centers, cancer institutes, government tenders, specialty distributors, and international pharmaceutical supply chains.

Darberel 100 mcg PFS Injection
Composition: Darbepoetin Alfa Injection 100 mcg/0.5 ml (Pre-Filled Syringe)
International Trade Name: Aranesp®

Darberel 100 mcg PFS is a high-quality Darbepoetin Alfa 100 mcg Injection, a biosimilar/generic equivalent of the internationally recognized erythropoiesis-stimulating agent (ESA) marketed under the brand name Aranesp®. Manufactured in WHO-GMP certified facilities under stringent biologics production standards, Darberel 100 mcg Injection is supplied by trusted pharmaceutical exporters from India to support global nephrology, oncology, and hematology treatment programs.

Darbepoetin alfa is a long-acting recombinant erythropoietin analog that stimulates red blood cell production by activating erythropoietin receptors in the bone marrow. Darberel 100 mcg PFS Injection is primarily indicated for the treatment of anemia associated with chronic kidney disease (CKD) and chemotherapy-induced anemia in cancer patients, helping reduce the need for blood transfusions when used according to clinical guidelines.

High-ranking search keywords include: Darbepoetin alfa 100 mcg injection, Darberel 100 mcg PFS, Aranesp biosimilar, darbepoetin price, anemia treatment injection, CKD anemia therapy, darbepoetin exporter India, and erythropoiesis stimulating agent supplier.

Darberel 100 mcg Darbepoetin Alfa Injection is manufactured under strict GMP and cold-chain controlled conditions, ensuring molecular integrity, consistent potency, and long-term stability. The pre-filled syringe (0.5 ml) format allows accurate dosing and ease of administration. The product is supplied in secure, export-grade packaging with complete regulatory and cold-chain documentation, making it suitable for dialysis centers, oncology hospitals, government supply programs, specialty distributors, and international pharmaceutical procurement channels.

Z-Taxel 300mg Injection
Composition: Paclitaxel Injection 300mg
International Trade Name: Taxol®

Z-Taxel 300 is a high-quality Paclitaxel 300mg Injection, a generic equivalent of the internationally recognized taxane-class chemotherapeutic agent marketed under the brand name Taxol®. Manufactured in WHO-GMP certified facilities, Z-Taxel 300 Injection is supplied by trusted pharmaceutical exporters from India to support global oncology treatment programs.

Paclitaxel is an antimicrotubule antineoplastic agent that promotes microtubule assembly and stabilizes them against depolymerization, thereby inhibiting normal microtubule dynamics required for cell division. Z-Taxel 300 Injection is primarily indicated for the treatment of breast cancer, ovarian cancer, non-small cell lung cancer (NSCLC), Kaposi’s sarcoma, and other solid tumors, either as monotherapy or in combination with other chemotherapeutic agents as per established protocols.

High-ranking search keywords include: Paclitaxel 300mg injection, Z-Taxel 300 injection, Taxol generic, paclitaxel price, taxane chemotherapy, oncology injectable exporter India, paclitaxel supplier, and anticancer injection manufacturer India.

Z-Taxel 300 Paclitaxel Injection is manufactured under strict GMP quality standards, ensuring consistent potency, accurate dosing, and long-term stability. The injection is supplied in secure, export-grade packaging with appropriate regulatory documentation, making it suitable for hospital oncology departments, cancer treatment centers, government supply programs, and international pharmaceutical distributors.

Decmax Dexamethasone 8mg Tablet
Composition: Dexamethasone Tablets 8mg
International Trade Names: Decadron® / Ozurdex® / Dexycu®

Decmax is a high-quality Dexamethasone 8mg Tablet, a generic equivalent of the internationally recognized corticosteroid marketed under well-known brand names such as Decadron®, Ozurdex®, and Dexycu® (different formulations and indications). Manufactured in WHO-GMP certified facilities, Decmax Tablets are supplied by trusted pharmaceutical exporters from India to support global hospital, oncology, immunology, and specialty care treatment programs.

Dexamethasone is a potent synthetic glucocorticoid with strong anti-inflammatory, immunosuppressive, and anti-edema properties. Decmax 8mg Tablets are widely indicated for the management of inflammatory and autoimmune disorders, allergic reactions, cerebral edema, hematological malignancies, and as a supportive medication in oncology for chemotherapy-induced nausea, hypersensitivity prevention, and tumor-related inflammation.

High-ranking search keywords include: Dexamethasone 8mg tablet, Decmax tablet, Decadron generic tablet, dexamethasone price, corticosteroid tablet, anti-inflammatory steroid, oncology supportive care drug, dexamethasone exporter India, and GMP steroid tablet manufacturer.

Decmax Dexamethasone 8mg Tablets are manufactured under strict GMP quality standards, ensuring consistent potency, accurate dosing, and long-term stability. The tablets are supplied in secure, export-grade packaging with appropriate regulatory documentation, making them suitable for hospitals, oncology centers, intensive care units, specialty clinics, government supply programs, and international pharmaceutical distributors.

Doxorex PL 2mg is a high-quality Liposomal Doxorubicin 2mg Injection, a generic equivalent of the internationally recognized pegylated liposomal anthracycline formulation marketed under the brand name Doxil®. Manufactured in WHO-GMP certified facilities using advanced liposomal drug delivery technology, Doxorex PL Injection is supplied by trusted pharmaceutical exporters from India to support global oncology treatment programs.

Liposomal doxorubicin is an encapsulated formulation of doxorubicin designed to enhance tumor targeting while reducing systemic toxicity. The liposomal delivery system prolongs circulation time and lowers cardiotoxicity compared to conventional doxorubicin. Doxorex PL 2mg Injection is primarily indicated for the treatment of ovarian cancer, multiple myeloma, Kaposi’s sarcoma, and breast cancer in specific clinical settings.

High-ranking search keywords include: Liposomal doxorubicin 2mg injection, Doxorex PL injection, Doxil generic, pegylated liposomal doxorubicin price, anthracycline chemotherapy, oncology injectable exporter India, and liposomal anticancer drug manufacturer India.

Doxorex PL 2mg Liposomal Doxorubicin Injection is manufactured under strict GMP quality standards, ensuring liposome integrity, consistent drug encapsulation, accurate dosing, and long-term stability. The injection is supplied in secure, export-grade packaging with appropriate regulatory documentation, making it suitable for hospital oncology departments, cancer institutes, government supply programs, and international pharmaceutical distributors.

Doxorex 50mg Injection
Composition: Doxorubicin Hydrochloride Injection 50mg
International Trade Name: Adriamycin®

Doxorex 50 is a high-quality Doxorubicin 50mg Injection, a generic equivalent of the internationally recognized anthracycline antineoplastic agent marketed under the brand name Adriamycin®. Manufactured in WHO-GMP certified facilities, Doxorex 50 Injection is supplied by trusted pharmaceutical exporters from India to support global oncology and hematology treatment programs.

Doxorubicin is an anthracycline antibiotic that intercalates DNA, inhibits topoisomerase II, and generates free radicals, leading to inhibition of DNA replication and apoptosis of rapidly dividing cancer cells. Doxorex 50mg Injection is widely indicated for the treatment of breast cancer, lymphomas, leukemias, sarcomas, ovarian cancer, and various other solid tumors, either as monotherapy or in combination chemotherapy regimens.

High-ranking search keywords include: Doxorubicin 50mg injection, Doxorex 50 injection, Adriamycin generic, doxorubicin price, anthracycline chemotherapy, oncology injectable exporter India, and anticancer injection manufacturer India.

Doxorex 50 Doxorubicin Injection is manufactured under strict GMP quality standards, ensuring consistent potency, accurate dosing, and long-term stability. The injection is supplied in secure, export-grade packaging with appropriate regulatory documentation, making it suitable for hospital oncology departments, cancer treatment centers, government supply programs, and international pharmaceutical distributors.

Cizumab 100mg Injection
Composition: Bevacizumab Injection 100mg
International Trade Name: Avastin®

Cizumab 100 is a high-quality Bevacizumab 100mg Injection, a biosimilar/generic equivalent of the internationally recognized anti-VEGF monoclonal antibody marketed under the brand name Avastin®. Manufactured in WHO-GMP certified facilities under stringent biologics production standards, Cizumab 100 Injection is supplied by trusted pharmaceutical exporters from India to support global oncology treatment programs.

Bevacizumab is a recombinant humanized monoclonal antibody that inhibits vascular endothelial growth factor (VEGF), thereby suppressing tumor angiogenesis and reducing blood supply to cancer cells. Cizumab 100mg Injection is indicated for the treatment of multiple malignancies, including colorectal cancer, non-small cell lung cancer (NSCLC), ovarian cancer, cervical cancer, renal cell carcinoma, and glioblastoma, in combination with standard chemotherapy regimens as per clinical guidelines.

High-ranking search keywords include: Bevacizumab 100mg injection, Cizumab 100 injection, Avastin biosimilar, bevacizumab price, anti-VEGF therapy, oncology monoclonal antibody exporter India, bevacizumab supplier, and cancer biologics manufacturer India.

Cizumab 100 Bevacizumab Injection is manufactured under strict GMP and cold-chain controlled conditions, ensuring molecular integrity, consistent potency, and long-term stability. The injection is supplied in secure, export-grade packaging with complete regulatory and cold-chain documentation, making it suitable for hospital oncology centers, cancer institutes, government tenders, specialty distributors, and international pharmaceutical supply chains.

Cresp 200 mcg Injection
Composition: Darbepoetin alfa Injection 200 mcg
International Trade Name: Nespo®

Cresp 200 is a high-quality Darbepoetin alfa 200 mcg Injection, a biosimilar equivalent of the internationally recognized erythropoiesis-stimulating agent (ESA) marketed under the brand name Nespo®. Manufactured in WHO-GMP certified facilities, Cresp Injection is supplied by trusted pharmaceutical exporters from India to support global nephrology, oncology, and hematology treatment programs.

Darbepoetin alfa is a long-acting recombinant erythropoietin analog that stimulates red blood cell production by binding to erythropoietin receptors in bone marrow. Cresp 200 mcg Injection is primarily indicated for the treatment of anemia associated with chronic kidney disease (CKD) and chemotherapy-induced anemia in cancer patients, helping reduce the need for blood transfusions and improve patient quality of life.

High-ranking search keywords include: Darbepoetin alfa 200 mcg injection, Cresp 200 injection, Nespo biosimilar, darbepoetin price, anemia in chronic kidney disease, chemotherapy-induced anemia treatment, ESA injection exporter India, and biologic manufacturer India.

Cresp 200 Darbepoetin alfa Injection is manufactured under stringent GMP and biologics quality standards, ensuring consistent potency, safety, and long-term stability. The injection is supplied in secure, cold-chain compliant, export-grade packaging with complete regulatory documentation, making it suitable for dialysis centers, oncology units, hospitals, government supply programs, and international pharmaceutical distributors.

Cresp 40 mcg Injection
Composition: Darbepoetin alfa Injection 40 mcg
International Trade Name: Nespo®

Cresp 40 is a high-quality Darbepoetin alfa 40 mcg Injection, a biosimilar equivalent of the internationally recognized erythropoiesis-stimulating agent (ESA) marketed under the brand name Nespo®. Manufactured in WHO-GMP certified facilities, Cresp Injection is supplied by reliable pharmaceutical exporters from India to support global nephrology, oncology, and hematology treatment programs.

Darbepoetin alfa is a long-acting recombinant erythropoietin analog that stimulates red blood cell production by activating erythropoietin receptors in the bone marrow. Cresp 40 mcg Injection is primarily indicated for the treatment of anemia associated with chronic kidney disease (CKD) and chemotherapy-induced anemia in cancer patients, helping to reduce transfusion requirements and improve hemoglobin levels.

High-ranking search keywords include: Darbepoetin alfa 40 mcg injection, Cresp 40 injection, Nespo biosimilar, darbepoetin price, anemia in CKD treatment, chemotherapy-induced anemia injection, ESA exporter India, and biologic manufacturer India.

Cresp 40 Darbepoetin alfa Injection is manufactured under stringent GMP and biologics quality standards, ensuring consistent efficacy, safety, and long-term stability. The injection is supplied in secure, cold-chain compliant, export-grade packaging with complete regulatory documentation, making it suitable for dialysis centers, oncology units, hospitals, government tenders, and international pharmaceutical distributors.

Darberel 200 mcg PFS Injection
Composition: Darbepoetin Alfa Injection 200 mcg/0.4 ml (Pre-Filled Syringe)
International Trade Name: Aranesp®

Darberel 200 mcg PFS is a high-quality Darbepoetin Alfa 200 mcg Injection, a biosimilar/generic equivalent of the internationally recognized erythropoiesis-stimulating agent (ESA) marketed under the brand name Aranesp®. Manufactured in WHO-GMP certified facilities under stringent biologics manufacturing standards, Darberel 200 mcg Injection is supplied by trusted pharmaceutical exporters from India to support global nephrology, oncology, and hematology treatment programs.

Darbepoetin alfa is a long-acting recombinant erythropoietin analog that stimulates red blood cell production by activating erythropoietin receptors in the bone marrow. Darberel 200 mcg PFS Injection is primarily indicated for the treatment of anemia associated with chronic kidney disease (CKD) and chemotherapy-induced anemia in cancer patients, helping reduce the need for blood transfusions when administered according to established clinical guidelines.

High-ranking search keywords include: Darbepoetin alfa 200 mcg injection, Darberel 200 mcg PFS, Aranesp biosimilar, darbepoetin price, anemia treatment injection, CKD anemia therapy, darbepoetin exporter India, and erythropoiesis stimulating agent supplier.

Darberel 200 mcg Darbepoetin Alfa Injection is manufactured under strict GMP and cold-chain controlled conditions, ensuring molecular integrity, consistent potency, and long-term stability. The pre-filled syringe (0.4 ml) format allows precise dosing and ease of administration. The product is supplied in secure, export-grade packaging with complete regulatory and cold-chain documentation, making it suitable for dialysis centers, oncology hospitals, government supply programs, specialty distributors, and international pharmaceutical procurement channels.

Bevatas 300mg Solution for Infusion
Composition: Bevacizumab Solution for Infusion 300mg
International Trade Name: Avastin®

Bevatas 300 is a high-quality Bevacizumab 300mg Solution for Infusion, a biosimilar/generic equivalent of the internationally recognized anti-VEGF monoclonal antibody marketed under the brand name Avastin®. Manufactured in WHO-GMP certified facilities under stringent biologics production standards, Bevatas 300 is supplied by trusted pharmaceutical exporters from India to support global oncology treatment programs.

Bevacizumab is a recombinant humanized monoclonal antibody that inhibits vascular endothelial growth factor (VEGF), thereby suppressing tumor angiogenesis and limiting blood supply to cancer cells. Bevatas 300 Solution for Infusion is indicated for the treatment of several malignancies, including colorectal cancer, non-small cell lung cancer (NSCLC), ovarian cancer, cervical cancer, renal cell carcinoma, and glioblastoma, in combination with standard chemotherapy regimens according to clinical guidelines.

High-ranking search keywords include: Bevacizumab 300mg infusion, Bevatas 300 infusion, Avastin biosimilar, bevacizumab price, anti-VEGF therapy, oncology monoclonal antibody exporter India, bevacizumab supplier, and cancer biologics manufacturer India.

Bevatas 300 Bevacizumab Solution for Infusion is manufactured under strict GMP and cold-chain controlled conditions, ensuring molecular integrity, consistent potency, and long-term stability. The infusion is supplied in secure, export-grade packaging with complete regulatory and cold-chain documentation, making it suitable for hospital oncology centers, cancer institutes, government tenders, specialty distributors, and international pharmaceutical supply chains.